Carcinogenic HPV infection in the cervical squamo-columnar junction

Journal of Pathology

Volumn 236, Issue 3, 2015, Pages 265-271

  Mirkovic, Jelena ^a   Howitt, Brooke E ^a   Roncarati, Patrick ^b   Demoulin, Stephanie ^b   Suarez Carmona, Meggy ^b   Hubert, Pascale ^b   McKeon, Frank D ^c   Xian, Wa ^c   Li, Anita ^a   Delvenne, Philippe ^b   Crum, Christopher P ^a   Herfs, Michael ^b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSITY OF LIÈGE   (Belgium)

^c JACKSON LABORATORY   (United States)

Author keywords

cervical intraepithelial neoplasia; HPV; squamo columnar junction

Indexed keywords

CALGRANULIN; CYCLIN DEPENDENT KINASE INHIBITOR 2A; KI 67 ANTIGEN; MESSENGER RNA; CAPSID PROTEIN; DNA BINDING PROTEIN; HPV L1 PROTEIN, HUMAN PAPILLOMAVIRUS; ONCOGENE PROTEIN E2, HUMAN PAPILLOMAVIRUS TYPE 1; ONCOPROTEIN; P16 PROTEIN, HUMAN; TUMOR PROTEIN; VIRUS DNA; VIRUS RNA;

ARTICLE; CARCINOGENICITY; CERVICAL SQUAMO COLUMNAR JUNCTION; CLINICAL ARTICLE; CONTROLLED STUDY; DNA ISOLATION; EXCISION; FEMALE; FEMALE GENITAL SYSTEM FUNCTION; GENE EXPRESSION; GENOTYPE; HIGH RISK PATIENT; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IN SITU HYBRIDIZATION; MICRODISSECTION; PAPILLOMAVIRUS INFECTION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGENY; SQUAMOUS INTRAEPITHELIAL LESION OF THE CERVIX; WART VIRUS; EPITHELIUM CELL; GENETICS; METABOLISM; PAPILLOMAVIRIDAE; PATHOLOGY; PHYSIOLOGY; UTERINE CERVIX; UTERINE CERVIX TUMOR; VIROLOGY; VIRUS CELL TRANSFORMATION;

CAPSID PROTEINS; CELL TRANSFORMATION, VIRAL; CERVIX UTERI; DNA, VIRAL; DNA-BINDING PROTEINS; EPITHELIAL CELLS; FEMALE; GENOTYPE; HUMANS; IN SITU HYBRIDIZATION; KI-67 ANTIGEN; NEOPLASM PROTEINS; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; RNA, VIRAL; UTERINE CERVICAL NEOPLASMS;

EID: 84930483725     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.4533     Document Type: Article

References (17)

1. Marsh M., Original site of cervical carcinoma; topographical relationship of carcinoma of the cervix to the external os and to the squamocolumnar junction. Obstet Gynecol 1956; 7: 444-452.
2. Richart RM,. Cervical intraepithelial neoplasia. Pathol Annu 1973; 8: 301-328.
3. Herfs M, Yamamoto Y, Laury A, et al., A discrete population of squamocolumnar junction cells implicated in the pathogenesis of cervical cancer. Proc Natl Acad Sci U S A 2012; 109: 10516-10521.
4. Wang X, Ouyang H, Yamamoto Y, et al., Residual embryonic cells as precursors of a Barrett's-like metaplasia. Cell 2011; 145: 1023-1035.
5. Herfs M, Parra-Herran C, Howitt BE, et al., Cervical squamocolumnar junction-specific markers define distinct, clinically relevant subsets of low-grade squamous intraepithelial lesions. Am J Surg Pathol 2013; 37: 1311-1318.
6. Chaturvedi AK,. Beyond cervical cancer: burden of other HPV-related cancers among men and women. J Adolesc Health 2010; 46: S20-S26.
7. Herfs M, Vargas SO, Yamamoto Y, et al., A novel blueprint for 'top down' differentiation defines the cervical squamocolumnar junction during development, reproductive life, and neoplasia. J Pathol 2013; 229: 460-468.
8. Herfs M, Hubert P, Poirrier AL, et al., Proinflammatory cytokines induce bronchial hyperplasia and squamous metaplasia in smokers: implications for chronic obstructive pulmonary disease therapy. Am J Respir Cell Mol Biol 2012; 47: 67-79.
9. Hubert P, Herman L, Roncarati P, et al., Altered α-defensin 5 expression in cervical squamocolumnar junction: implication in the formation of a viral/tumour permissive microenvironment. J Pathol 2014; 234: 464-477.
10. Xue Y, Bellanger S, Zhang W, et al., HPV16 E2 is an immediate early marker of viral infection, preceding E7 expression in precursor structures of cervical carcinoma. Cancer Res 2010; 70: 5316-5325.
11. Kocjan BJ, Seme K, Poljak M,. Comparison of the Abbott RealTime High Risk HPV test and INNO-LiPA HPV Genotyping Extra test for the detection of human papillomaviruses in formalin-fixed, paraffin-embedded cervical cancer specimens. J Virol Methods 2011; 175: 117-119.
12. Ernoux-Neufcoeur P, Arafa M, Decaestecker C, et al., Combined analysis of HPV DNA, p16, p21 and p53 to predict prognosis in patients with stage IV hypopharyngeal carcinoma. J Cancer Res Clin Oncol 2011; 137: 173-181.
13. Kong CS, Balzer BL, Troxell ML, et al., p16INK4A immunohistochemistry is superior to HPV in situ hybridization for the detection of high-risk HPV in atypical squamous metaplasia. Am J Surg Pathol 2007; 31: 33-43.
14. van der Marel J, van Baars R, Alonso I, et al., Oncogenic human papillomavirus-infected immature metaplastic cells and cervical neoplasia. Am J Surg Pathol 2014; 38: 470-479.
15. Mitao M, Nagai N, Levine RU, et al., Human papillomavirus type 16 infection: a morphological spectrum with evidence for late gene expression. Int J Gynecol Pathol 1986; 5: 287-296.
16. Taylor S, Wang C, Wright TC, et al., Reduced acquisition and reactivation of human papillomavirus infections among older women treated with cryotherapy: results from a randomized trial in South Africa. BMC Med 2010; 8: 40.
17. Moscicki AB, Ma Y, Wibbelsman C, et al., Rate of and risks for regression of cervical intraepithelial neoplasia 2 in adolescents and young women. Obstet Gynecol 2010; 116: 1373-1380.